profit from every $100 of sales.
$0$100
Solana
$1.73-8.47% today
-64.8% in 1 year
1-year low $1.271-year high $4.91
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Solana sold, what it kept, and what it did with the cash.
Sales went from $787,000 in 2022 to $6.02 million in 2025, with -$40.9 million of profit last year.
SalesProfit
Solana vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Solana | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Solana's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1 | 1 | 1 | 6 | |
| 0 | 0 | -0 | 6 | |
| -15 | -12 | -14 | -21 | |
| -15 | -12 | -12 | -40 | |
| -14 | -9 | -12 | -41 | |
| -18,712.77 | -9,296.22 | -3,282.26 | -1.85 | |
| 41.2% | 9.5% | -11.9% | 91.7% | |
| -1,875.3% | -1,905.1% | -2,673.7% | -351.0% | |
| -1,788.1% | -1,374.2% | -2,258.1% | -679.6% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 17 | 8 | 4 | 304 |
| Cash | 15 | 5 | 1 | 7 |
| Total debt | 0 | 0 | 0 | – |
| Total liabilities | 9 | 5 | 2 | 3 |
| 8 | 2 | 1 | 301 | |
| 0 | 0 | 0 | 22 | |
| -141.1% | -402.7% | -864.9% | -10.6% | |
| -172.6% | -376.6% | -1,108.8% | -13.6% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -14 | -10 | -11 | -17 | |
| 0 | 0 | 0 | 45 | |
| -14 | -10 | -11 | -61 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 2 | 2 | 3 | 9 |
Valuation
- –
- –
- –
- 0.2×
- 18.1×
- –
- –
- -56.3%
- -37.6%
- 0.0%
Profitability
- 91.7%
- -351.0%
- -679.6%
- -669.0%
- -7.0%
- -361.8%
- -105.0%
- -13.5%
- -7.0%
- 58.4%
Growth
- +97.0%
- –
- −454.9%
- –
- +287.0%
Financial health
- -0.2×
- 0.00
- 0.0%
- 33.3×
- 10.33
- 10.33
- 0.02
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 30%of 946
Top 6%of 868
Bottom 1%of 986
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 15, 2026 | -1.30 | -0.34 | −282.4% |
| Mar 30, 2026 | 4.25 | -26.50 | +116.0% |
| Nov 18, 2025 | -32.89 | -50.50 | +34.9% |
| Aug 14, 2025 | -79.73 | -128.50 | +38.0% |
| May 1, 2025 | -382.31 | -8.70 | −4,294.4% |
| Mar 25, 2025 | -1.03 | -0.94 | −9.6% |
| Nov 12, 2024 | -0.99 | -1.06 | +6.6% |
| Aug 12, 2024 | -0.64 | -0.50 | −28.0% |
News
The Price of Solana Just Dropped Below $100. Time to Buy the Dip?Yahoo Finance · Nov 6, 2026A Major New Solana Blockchain Upgrade Is Now Live. But Here's Why Blockchain Upgrades Rarely Move the Needle for Crypto.Yahoo Finance · Oct 30, 2026Better Buy: Solana vs. XRPYahoo Finance · Oct 24, 2026Here's Why I'm Buying Solana Right NowYahoo Finance · Oct 15, 2026Solana ETFs Just Set a New Record With $188 Million in Weekly Inflows. Here's Why I'm Bullish on Solana for 2027.Yahoo Finance · Oct 11, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
59No pass
Benjamin Graham
75Pass
Philip Fisher
63Pass
Peter Lynch
100Pass
Joel Greenblatt
2No pass
Charlie Munger
55No pass
Terry Smith
58No pass
Questions about Solana
Is Solana a good stock to buy?
A business with weak numbers that is not profitable yet. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Solana AI analysis
What does Solana do?
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. It is in Medical - Devices.
Does Solana pay a dividend?
No. Solana does not pay a dividend at the moment.
Is Solana stock halal?
Yes. Solana passes our halal screen: its business is permitted and its debt is 0% of its market value, under the 30% limit. How we check
How has Solana stock done over the past year?
Down 64.8% over the past twelve months, to $1.73. It traded between $1.27 and $4.91 and is 64.8% below its high.
Who are Solana's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Solana's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.